The optimal mode of treatment of undescended testes and the optimal age for intervention has been discussed for decades, without reaching a worldwide consensus. Numerous publications report on the anatomical outcome of various treatment modalities, where ‘success’ is defined as a testis in the scrotum, without obvious atrophy. The real goal of treatment, to achieve normal or at least improved spermatogenesis in the undescended testis, has not attracted the same number of clinical scientists. The reason is obvious – treatment is carried out in childhood, while the final outcome as to testicular function has to await full pubertal development, many years later. Prospective, randomised and controlled studies, from childhood to adulthood, comparing different modes of treatment and different ages for intervention would be required to reach final conclusions. Such studies have so far not been published. However, cryptorchidism is the most common abnormality of newborn boys, with an incidence at birth of 3–9%, decreasing to 1–2% of all boys at 3–6 months of age. Therefore, clinical guidelines are needed, even if the final conclusions from long-term prospective studies are lacking. Therapeutic traditions have governed the management of undescended testes more than scientific facts. This is probably the reason why both the mode and the timing of treatment show strong local variance. Thus, in many parts of Europe, hormonal treatment at 2–4 years of age is recommended, while surgery at an early age is preferred in North America. This strategy of early treatment is based on histopathological observations of decreased number of spermatogonia in seminiferous tubules in undescended testes from age 2 years and on. However, hard evidence for better spermatogenesis achieved by very early surgery has been scarce. Over the past few years, evidence has accumulated that hormonal therapy (mostly through injection of human chorionic gonadotropin, hCG) is not very effective (as measured by a scrotal position after treatment), and may even damage future spermatogenesis through increased apoptosis. Emerging evidence also suggests that surgery before one year of age results in better postoperative testicular growth than orchiopexy at age 3 years. These findings and others prompted a meeting of Nordic experts in the fields of paediatric endocrinology, urology, pathology and anaesthesiology as well as testicular physiology. Consensus on treatment was reached, based on present knowledge: Surgery is preferred to hormonal therapy, and surgery should be carried out before 1 year of age. Since surgery at that age requires specially trained paediatric urologists/surgeons and anaesthesiologists, it should only be performed in centres with such facilities. The reasons behind the recommendations are presented in this issue of Acta Paediatrica as one common consensus statement by all participants, joined by five reviews on different aspects on the treatment of undescended testicles. I am convinced that both practicing paediatricians and specialized experts in the field will find these articles very interesting. We are very grateful that one of the front clinical scientists in the area, Professor John Hutson, from the Royal Children’s Hospital in Melbourne, has written a commentary to this series of papers.
Read full abstract